Skip to main content
. 2022 May 19;17(2):138–145. doi: 10.5114/pg.2022.116373

Table III.

Distribution of the post-treatment endoscopic findings

Variable Group 1 n (%) Group 2 n (%) Group 3 n (%) Group 4 n (%) P-value
Endoscopic antral gastritis 16 (32) 24 (48) 21 (42) 24 (48) 0.32
Endoscopic erythematous pangastritis 7 (14) 9 (18) 6 (12) 9 (18) 0.79
Endoscopic erythematous bulbitis 8 (16) 9 (18) 7 (14) 9 (18) 0.94
Gastric ulcer 3 (6) 8 (16) 2 (4) 8 (16) 0.08
Bulbus ulcer 4 (8) 2 (4) 1 (2) 2 (4) 0.27